SCHEMBL6909295

SCHEMBL6909295

CCn1c(=O)[nH]c2cc(F)c(F)cc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
LMNA P02545 1/20 0.65
CYP3A4 P08684 1/20 0.65
CYP2D6 P10635 1/20 0.65
TSHR P16473 1/20 0.65
NFKB1 P19838 1/20 0.65
BLM P54132 1/20 0.65
PMP22 Q01453 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
DAO P14920 3/20 0.56
MAOB P27338 3/20 0.49
PGR P06401 4/20 0.48
GRIA1 P42261 1/20 0.45
GRIA2 P42262 1/20 0.45
GRIA3 P42263 1/20 0.45
GRIA4 P48058 1/20 0.45
B3GNT2 Q9NY97 1/20 0.39
MPO P05164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6904350 0.80 CYP1A2 (0.67) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL31481931 0.79 MAOB (0.64) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL6907750 0.79 MAOB (0.64) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL4077298 0.79 CYP1A2 (0.60) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL8139335 0.79 CYP1A2 (0.45) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL7063351 0.79 CYP1A2 (0.65) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL612079 0.79 CYP1A2 (1.00) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL6799574 0.79 CYP1A2 (0.65) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL29701185 0.79 CYP1A2 (1.00) CYP1A2MEN1KMT2ALMNACYP3A4
SCHEMBL23997304 0.77 PGR (0.56) MEN1KMT2ALMNACYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039409-A2 COMPOSITION COMPRISING ACTIVATORS OF IK POTASSIUM CHANNELS AND CALCINEURIN ANTAGONISTS AND USE THEREOF SWITCH BIOTECH AG (DE) 2004-05-13 WO claimed